Retour à ReACT Therapeutics
Emile Roussel (Co-founder & CEO,  ReACT Therapeutics)

Publié le jeudi 16 novembre 2023 11:12 sur la page de l'organisation ReACT Therapeutics

ReACT was a top 100 French startups from academic research for Deeptech Connect's 100% business day

ReACT Therapeutics was among the 100 startups selected to participate in Deeptech Connect 2023, a 100% business-focused event organized by the SATT Network in Paris on November 14, 2023.

 

Lise, CSO, and Emile, CEO of ReACT Therapeutics, had the opportunity to engage with numerous individuals, and Emile had the chance to deliver a 2-minute pitch in front of a panel of investors, entrepreneurs, and representatives from the French innovation ecosystem.